The short answer: Daily hydroxyzine is an approved use, but the evidence stops early. The FDA label for hydroxyzine hydrochloride says its effectiveness for anxiety beyond 4 months has not been assessed by systematic clinical studies. The main trials in generalized anxiety disorder (GAD) lasted 4 to 12 weeks. Daily use is a poor fit for adults 65 and older, for people with a prolonged QT interval, and in early pregnancy.

What does the FDA label say about daily use?

The label allows a daily schedule. It lists hydroxyzine for "symptomatic relief of anxiety and tension associated with psychoneurosis." For adults with anxiety, it gives 50 to 100 mg four times a day. MedlinePlus describes a schedule of three or four times a day, or as your doctor directs.

The label then sets a limit on what is known. It states that effectiveness as an antianxiety agent for long-term use, "that is more than 4 months, has not been assessed by systematic clinical studies." It tells the physician to reassess periodically how useful the drug is for each patient.

That sentence does not say hydroxyzine becomes harmful at 4 months. It says nobody has tested it properly past that point. The label for hydroxyzine pamoate capsules carries the same statement. Both forms deliver the same active drug.

Many people take hydroxyzine only on hard days. This article covers the daily schedule. For how it compares with a drug built for daily use, see our post on buspirone vs hydroxyzine for anxiety.

How long did the trials of daily hydroxyzine last?

The trials were short. Three randomized, placebo-controlled trials in GAD show the range:

  • 4 weeks. A 1994 French trial gave 133 patients hydroxyzine 50 mg a day or placebo.
  • 4 weeks. A 1998 trial in France and the UK assigned 244 patients to hydroxyzine 50 mg a day, buspirone, or placebo. Anxiety scores improved by 10.75 points with hydroxyzine and 7.23 points with placebo.
  • 12 weeks. A 2002 trial randomized 334 outpatients to hydroxyzine 50 mg a day, bromazepam, or placebo. The mean drop in the Hamilton anxiety score was 12.16 points with hydroxyzine and 9.64 with placebo (p = .019).

Twelve weeks is the longest of these. All three trials used 50 mg a day, which is below the label's adult range. Your prescriber sets your dose.

The Cochrane review of hydroxyzine for GAD pooled five trials with 884 participants. Hydroxyzine was more effective than placebo. The authors still found a high risk of bias, few studies, and a small total sample. They concluded that it is not possible to recommend hydroxyzine as a reliable first-line treatment for GAD.

Does the drowsiness wear off if you take it every day?

For many people, yes. The label says drowsiness "is usually transitory and may disappear in a few days of continued therapy or upon reduction of dose."

The 1994 trial saw the same pattern. Sleepiness affected 28% of the hydroxyzine group and 14% of the placebo group. It appeared in the first week and then faded during treatment. Dry mouth affected 14% of the hydroxyzine group and 5% of the placebo group.

This has a second side. If you take hydroxyzine to fall asleep, the sleep effect can fade too. The 2023 AGS Beers Criteria note that tolerance develops when first-generation antihistamines are used as a hypnotic (a sleep aid). Our sibling site insomnia.md covers sleep treatments. We also explain why anxiety keeps you awake.

Less drowsiness does not prove that you are safe to drive. The label says patients should be cautioned against driving or operating dangerous machinery while taking hydroxyzine. MedlinePlus says not to drive until you know how the drug affects you.

Alcohol adds to the problem. The label warns that the effects of alcohol may be increased. It also advises against other central nervous system depressants at the same time. Alcohol can also worsen anxiety by itself, as we explain in why anxiety is worse after drinking.

Why is daily use riskier for older adults?

Hydroxyzine is an anticholinergic drug. It blocks acetylcholine, a chemical messenger used in memory, bowel function, and bladder control. The effect adds up with every other anticholinergic medicine a person takes. Doctors call the total the anticholinergic burden.

The 2023 AGS Beers Criteria list hydroxyzine among the first-generation antihistamines to avoid in adults 65 and older. The recommendation is rated strong, with moderate quality of evidence. The panel gives these reasons:

  • The drugs are highly anticholinergic.
  • Clearance is reduced with advanced age.
  • There is a risk of confusion, dry mouth, constipation, and other anticholinergic effects.
  • Cumulative exposure to anticholinergic drugs is associated with an increased risk of falls, delirium, and dementia.

The panel adds that the link with cumulative exposure appears "even in younger adults." It asks clinicians to consider total anticholinergic burden during regular medication reviews. That is the main reason daily use deserves more thought than occasional use. An association does not prove that the drug causes dementia.

The FDA label is more cautious in tone but points the same way. It says sedating drugs may cause confusion and over-sedation in the elderly. MedlinePlus states that older adults should not usually take hydroxyzine, because it is not as safe as other medicines for the same condition.

Who should not take hydroxyzine every day?

The label names several groups. The heart warning is the most serious.

People with a prolonged QT interval. The QT interval is the time the heart takes to recharge between beats. The label says hydroxyzine is contraindicated in patients with a prolonged QT interval. It reports cases of QT prolongation and Torsade de Pointes, a dangerous heart rhythm, during post-marketing use. Most reports involved people with other risk factors.

The label advises caution for people with these risks:

  • pre-existing heart disease, recent heart attack, uncompensated heart failure, or a slow heartbeat
  • electrolyte imbalances
  • congenital long QT syndrome or a family history of it
  • other drugs that prolong the QT interval

The label's examples of such drugs include citalopram, fluoxetine, quetiapine, azithromycin, methadone, and ondansetron. Some of these are common anxiety and depression medicines. Give your prescriber and pharmacist a full medicine list.

European regulators went further than the US label. The European Medicines Agency review of hydroxyzine, completed in 2015, confirmed the QT risk. It restricted use to the lowest effective dose for the shortest possible duration.

People in early pregnancy. The label says hydroxyzine caused fetal abnormalities in rats and mice at doses substantially above the human therapeutic range. It says human data "are inadequate to establish safety in early pregnancy." Until such data exist, the label lists early pregnancy as a contraindication. MedlinePlus says to call your doctor immediately if you become pregnant while taking it.

People who are breastfeeding. The label says it is not known whether the drug passes into human milk. It says hydroxyzine should not be given to nursing mothers.

The label also lists allergy to hydroxyzine, cetirizine, or levocetirizine as a contraindication.

What happens when you stop taking it?

The evidence is limited but reassuring. Hydroxyzine is not a benzodiazepine, and its label has no drug abuse and dependence section.

In the 1994 trial, treatment stopped abruptly after 4 weeks. The benefit over placebo persisted one week later. The authors reported no rebound of anxiety and no withdrawal symptoms.

That finding covers 4 weeks of use at 50 mg a day. We found no trial that tested stopping after many months or years. Anxiety can also return because the underlying condition is still there. Talk to your prescriber before you stop a daily medicine.

The bottom line

Daily hydroxyzine is an approved, short-term way to ease anxiety. Trials support it for 4 to 12 weeks, and the label says use beyond 4 months has not been studied. The drowsiness often fades, but the anticholinergic effects and the QT warning stay. Adults 65 and older, people with heart rhythm risks, and people who are pregnant or breastfeeding should ask about other options. If you take it daily, ask your prescriber to review the plan at regular intervals.

Last updated: October 2026. This article is for informational purposes only and does not constitute medical advice. Do not start, stop, or change the dose of hydroxyzine without talking to your prescriber or pharmacist.